{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:51:01Z","timestamp":1791215461036,"version":"4.1.0"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijid.2026.108933","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T14:22:19Z","timestamp":1782656539000},"page":"108933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dolutegravir improves physical health-related quality of life in adults with HTLV-1 infection: A randomized controlled trial"],"prefix":"10.1016","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3736-0002","authenticated-orcid":false,"given":"Liliane","family":"Lins-Kusterer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Monta\u00f1o-Castell\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estela","family":"Luz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Belen","family":"Arriaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana Luz","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby Brooke","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Brites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ijid.2026.108933_bib0001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008761","article-title":"Health state utility values in people living with HTLV-1 and in patients with HAM\/TSP: the impact of a neglected disease on the quality of life","volume":"14","author":"Rosadas","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.ijid.2026.108933_bib0002","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s43856-025-01312-9","article-title":"Dolutegravir use is related to lower HTLV-1 proviral load in people co-infected by HIV-1","volume":"6","author":"Fernandez","year":"2025","journal-title":"Commun Med"},{"key":"10.1016\/j.ijid.2026.108933_bib0003","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciag163","article-title":"Dolutegravir reduces human T-cell lymphotropic virus type 1 proviral load and improves neurological outcomes in a phase 2 controlled trial","author":"Brites","year":"2026","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2026.108933_bib0004","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1590\/s0004-2803.202202000-36","article-title":"Validation of the RAND 36-item Health Survey questionnaire in Brazil","volume":"59","author":"Lins-Kusterer","year":"2022","journal-title":"Arq Gastroenterol"},{"issue":"November","key":"10.1016\/j.ijid.2026.108933_bib0005","first-page":"1","article-title":"Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs","volume":"4","author":"Lakens","year":"2013","journal-title":"Front Psychol"},{"key":"10.1016\/j.ijid.2026.108933_bib0006","doi-asserted-by":"crossref","first-page":"p. 1123","DOI":"10.1136\/bmj.323.7321.1123","article-title":"Analysing controlled trials with baseline and follow up measurements","volume":"323","author":"Vickers","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.ijid.2026.108933_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/0037-8682-0759-2020","article-title":"Comparison of functioning and health-related quality of life among patients with HTLV-1, HIV, and HIV-HTLV-1-coinfection","volume":"54","author":"Marconi","year":"2021","journal-title":"Rev Soc Bras Med Trop"},{"issue":"5","key":"10.1016\/j.ijid.2026.108933_bib0008","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00005650-200305000-00006","article-title":"Interpreting health-related quality of life scores","volume":"41","author":"Wright","year":"2003","journal-title":"Med Care"},{"issue":"5","key":"10.1016\/j.ijid.2026.108933_bib0009","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life","volume":"41","author":"Norman","year":"2003","journal-title":"Med Care"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226005680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226005680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:54:00Z","timestamp":1791212040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226005680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":9,"alternative-id":["S1201971226005680"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108933","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dolutegravir improves physical health-related quality of life in adults with HTLV-1 infection: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108933","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108933"}}